During the past decade, Centro Oncologico Estatal ISSEMYM conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Oncologico Estatal ISSEMYM" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Aragon Pharmaceuticals, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Oncologico Estatal ISSEMYM" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Latin American Cooperative Oncology Group" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Centro Oncologico Estatal ISSEMYM" are "Breast Cancer" (4 trials), "Cancer of Unknown Primary Site" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervical Cancer" (1 trials) and "Mesothelioma" (1 trials). Many other conditions were trialed in "Centro Oncologico Estatal ISSEMYM" in a lesser frequency.

Most popular intervention types in "Centro Oncologico Estatal ISSEMYM" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (4 trials), "Pertuzumab" (4 trials), "Docetaxel" (3 trials), "Trastuzumab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Oncologico Estatal ISSEMYM" are 7 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Oncologico Estatal ISSEMYM". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centro Oncologico Estatal ISSEMYM, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Oncologico Estatal ISSEMYM, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".